Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,401 | -5,360 | -24,457 | -18,267 | -13,149 |
| Depreciation Amortization | 145 | 74 | 260 | 190 | 123 |
| Accounts receivable | 624 | 323 | 335 | N/A | N/A |
| Other Working Capital | 1,524 | 1,093 | -3,434 | -3,406 | -2,019 |
| Other Operating Activity | 286 | 182 | 1,031 | 726 | 748 |
| Operating Cash Flow | $-9,822 | $-3,688 | $-26,265 | $-20,757 | $-14,297 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1 | -8 | 653 | 1,915 | -18 |
| PPE Investments | -28 | -9 | -330 | -295 | -58 |
| Investing Cash Flow | $-29 | $-17 | $323 | $1,620 | $-76 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 5 | 5 | 5 |
| Other Financing Activity | 0 | 0 | 6,964 | 6,998 | 7,104 |
| Financing Cash Flow | $N/A | $N/A | $6,969 | $7,003 | $7,109 |
| Beginning Cash Position | 18,856 | 18,856 | 37,829 | 37,829 | 37,829 |
| End Cash Position | 9,005 | 15,151 | 18,856 | 25,695 | 30,565 |
| Net Cash Flow | $-9,851 | $-3,705 | $-18,973 | $-12,134 | $-7,264 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,822 | -3,688 | -26,265 | -20,757 | -14,297 |
| Capital Expenditure | -28 | -9 | -330 | -295 | -58 |
| Free Cash Flow | -9,850 | -3,697 | -26,595 | -21,052 | -14,355 |